Bridge to durable left ventricular assist device for refractory cardiogenic shock

Journal of Thoracic and Cardiovascular Surgery

Volumn 153, Issue 4, 2017, Pages 752-762.e5

  Yoshioka, Daisuke ^a   Takayama, Hiroo ^a   Garan, Arthur R ^a   Topkara, Veli K ^a   Han, Jiho ^a   Li, Boyganzi ^a   Kurlansky, Paul ^a   Yuzefpolskaya, Melana ^a   Colombo, Paolo C ^a   Naka, Yoshifumi ^a   Takeda, Koji ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

bridge to bridge; cardiogenic shock; left ventricular assist device; short term mechanical circulatory support

Indexed keywords

ADULT; ASSISTED CIRCULATION; BLOOD PUMP; BRIDGE TO BRIDGE THERAPY; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HOSPITAL MORTALITY; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MALE; MIDDLE AGED; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; TREATMENT DURATION; CONVALESCENCE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PROSTHESIS DESIGN; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; FEMALE; HEART-ASSIST DEVICES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 85008400367     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2016.10.085     Document Type: Conference Paper

References (28)

1. 1 Estep, J.D., Starling, R.C., Horstmanshof, D.A., Milano, C.A., Selzman, C.H., Shah, K.B., et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study. J Am Coll Cardiol 66 (2015), 1747–1761.
2. 2 Miller, L.W., Pagani, F.D., Russell, S.D., John, R., Boyle, A.J., Aaronson, K.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007), 885–896.
3. 3 Slaughter, M.S., Rogers, J.G., Milano, C.A., Russell, S.D., Conte, J.V., Feldman, D., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
4. 4 Kirklin, J.K., Naftel, D.C., Pagani, F.D., Kormos, R.L., Stevenson, L.W., Blume, E.D., et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34 (2015), 1495–1504.
5. 5 Riebandt, J., Haberl, T., Mahr, S., Laufer, G., Rajek, A., Steinlechner, B., et al. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg 46 (2014), 486–492.
6. 6 Shah, P., Smith, S., Haft, J.W., Desai, S.S., Burton, N.A., Romano, M.A., et al. Clinical outcomes of advanced heart failure patients with cardiogenic shock treated with temporary circulatory support before durable LVAD implant. ASAIO J 62 (2016), 20–27.
7. 7 Takayama, H., Soni, L., Kalesan, B., Truby, L.K., Ota, T., Cedola, S., et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 7 (2014), 799–806.
8. 8 Truby, L., Mundy, L., Kalesan, B., Kirtane, A., Colombo, P.C., Takeda, K., et al. Contemporary outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock at a large tertiary care center. ASAIO J 61 (2015), 403–409.
9. 9 Takayama, H., Yang, J.A., Naka, Y., Tips on tuning each device: technical pearls. Cardiol Clin 29 (2011), 551–556.
10. 10 Cowger, J., Sundareswaran, K., Rogers, J.G., Park, S.J., Pagani, F.D., Bhat, G., et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 61 (2013), 313–321.
11. 11 Boyle, A.J., Ascheim, D.D., Russo, M.J., Kormos, R.L., John, R., Naka, Y., et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 30 (2011), 402–407.
12. 12 Adamo, L., Nassif, M., Tibrewala, A., Novak, E., Vader, J., Silvestry, S.C., et al. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients. JACC Heart Fail 3 (2015), 283–290.
13. 13 Butler, J., Geisberg, C., Howser, R., Portner, P.M., Rogers, J.G., Deng, M.C., et al. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg 81 (2006), 1745–1751.
14. 14 Lietz, K., Long, J.W., Kfoury, A.G., Slaughter, M.S., Silver, M.A., Milano, C.A., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007), 497–505.
15. 15 Sandner, S.E., Zimpfer, D., Zrunek, P., Rajek, A., Schima, H., Dunkler, D., et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 87 (2009), 1072–1078.
16. 16 Yoshioka, D., Sakaguchi, T., Saito, S., Miyagawa, S., Nishi, H., Yoshikawa, Y., et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation. Circ J 76 (2012), 1631–1638.
17. 17 Kormos, R.L., Teuteberg, J.J., Pagani, F.D., Russell, S.D., John, R., Miller, L.W., et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139 (2010), 1316–1324.
18. 18 Takeda, K., Naka, Y., Yang, J.A., Uriel, N., Colombo, P.C., Jorde, U.P., et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant 33 (2014), 141–148.
19. 19 Chan, C.M., Klinger, J.R., The right ventricle in sepsis. Clin Chest Med 29 (2008), 661–676 ix.
20. 20 Lahm, T., McCaslin, C.A., Wozniak, T.C., Ghumman, W., Fadl, Y.Y., Obeidat, O.S., et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 56 (2010), 1435–1446.
21. 21 Meldrum, D.R., Tumor necrosis factor in the heart. Am J Physiol 274 (1998), R577–R595.
22. 22 Saito, S., Sakaguchi, T., Miyagawa, S., Nishi, H., Yoshikawa, Y., Fukushima, S., et al. Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure. J Heart Lung Transplant 31 (2012), 858–864.
23. 23 Toda, K., Fujita, T., Kobayashi, J., Shimahara, Y., Kitamura, S., Seguchi, O., et al. Impact of preoperative percutaneous cardiopulmonary support on outcome following left ventricular assist device implantation. Circ J 76 (2012), 88–95.
24. 24 Meineri, M., Van Rensburg, A.E., Vegas, A., Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol 26 (2012), 217–229.
25. 25 Stretch, R., Sauer, C.M., Yuh, D.D., Bonde, P., National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64 (2014), 1407–1415.
26. 26 Werdan, K., Gielen, S., Ebelt, H., Hochman, J.S., Mechanical circulatory support in cardiogenic shock. Eur Heart J 35 (2014), 156–167.
27. 27 Goldstein, D.J., Maybaum, S., MacGillivray, T.E., Moore, S.A., Bogaev, R., Farrar, D.J., et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail 18 (2012), 392–395.
28. 28 Guglin, M., Miller, L., Myocardial recovery with left ventricular assist devices. Curr Treat Options Cardiovasc Med 14 (2012), 370–383.